MedTrace Logo

Observational Study of C. Diff in Post-Transplant Patients

NCT02747017 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2019-11-01

No results posted yet for this study

Summary

The primary objective of this observational study is to estimate the 90-day response rates to treatment for a first episode of C. difficile infections (CDI) in adult transplant recipients.

Conditions

  • Clostridium Difficile

Sponsors & Collaborators

  • International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

    collaborator NETWORK

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Copenhagen HIV Programme

    collaborator OTHER_GOV

  • Medical Research Council

    collaborator OTHER_GOV

  • Washington D.C. Veterans Affairs Medical Center

    collaborator FED

  • University of Minnesota

    lead OTHER

Principal Investigators

  • Jean-Michel Molina, MD · Hôpital Saint-Louis, Service de Maladies Infectieuses

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-22
Primary Completion
2018-10-30
Completion
2018-10-30

Countries

  • United States
  • Argentina
  • Denmark
  • Germany
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02747017 on ClinicalTrials.gov